Atlas Trials

Phase II Study Using CHFR Methylation Status in Patients With Metastatic Esophageal, Gastroesophageal, Gastric Cancer.

Clinical trial NCT01715233 · COMPLETED

Trial details

NCT number
NCT01715233
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Esophageal CancerGastroesophageal CancerGastric Cancer
Start date
2012-12-01
Primary completion
2015-06-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.